Archive: 29/08/2012

Afinitor disperz approved for rare pediatric cancer

(HealthDay)—The U.S. Food and Drug Administration has approved Afinitor Disperz (everolimus tablets for oral suspension), the first form of the anti-cancer drug Afinitor to be created especially for children.

Smokers more than double their risk of burst aneurysm

Smoking more than 20 cigarettes a day doubles the risk of a potentially fatal brain bleed as a result of a burst aneurysm, finds research published online in the Journal of Neurology Neurosurgery and Psychiatry.

page 1 from 8